美股市場個股詳情

RCKT Rocket Pharmaceuticals

添加自選
  • 13.130
  • +0.090+0.69%
交易中 11/21 15:31 (美東)
11.97億總市值-4809市盈率TTM

關於Rocket Pharmaceuticals公司

Rocket Pharmaceuticals Inc 是一家後期生物製藥公司。公司專注於開發罕見和毀滅性兒科疾病的基因療法。公司的渠道產品包括用於Danaon病的RP-A501、用於範可尼貧血的RP-L102、用於白細胞粘附的RP-L201、用於丙酮酸激酶缺乏症的RP-L301和用於嬰兒惡性骨質疏鬆症的RP-L401。

公司介紹

公司代碼RCKT
公司名稱Rocket Pharmaceuticals
上市日期2015/02/18
發行價格6.00
成立日期1999
CEODr. Gaurav Shah, M.D.
所屬市場納斯達克
員工數量268
年結日12-31
公司地址9 Cedarbrook Drive
城市Cranbury
省份新澤西
國家美國
郵編08512
電話1-609-659-8001

董事高管

  • 姓名
  • 職務
  • 年薪
  • Dr. Gaurav Shah, M.D.
  • Director and Chief Executive Officer
  • 801.36萬
  • Aaron Ondrey
  • Chief Financial Officer
  • --
  • Mayo Pujols
  • Chief Technical Officer and Executive Vice President
  • 437.77萬
  • Martin Wilson, J.D.
  • Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
  • --
  • Jonathan Schwartz, M.D.
  • Chief Medical Officer and Chief Gene Therapy Officer
  • 315.78萬
  • Raj Prabhakar
  • Chief Business Officer and Senior Vice President
  • --
  • Dr. Kinnari Patel, M.B.A.,Pharm.D.
  • President, Chief Operating Officer and Head of R&D
  • 484.61萬
  • Mark White
  • General Manager, Commercial Affairs
  • --
  • John Militello, C.P.A.
  • Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
  • 152.76萬
  • Dr. Roderick Wong, M.D.
  • Chairman of the Board
  • 41.00萬
  • Dr. Mikael Dolsten, M.D.
  • Director
  • --
  • Pedro P. Granadillo
  • Independent Director
  • 43.00萬
  • Dr. Fady Ibraham Malik, M.D.,PhD
  • Independent Director
  • 40.00萬
  • David P. Southwell
  • Independent Director
  • 40.00萬
  • Dr. Naveen Yalamanchi, M.D.
  • Independent Director
  • 41.75萬
  • Dr. Elisabeth Bjork, M.D.,PhD
  • Independent Director
  • 41.00萬
  • Dr. Gotham Makker, M.D.
  • Independent Director
  • 40.00萬
  • Carsten Boess
  • Independent Director
  • 42.75萬
  • Robert Keith Woods
  • Independent Director
  • 56.87萬

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議
美股
綜合熱度
股票代碼
最新價
升跌幅

暫無數據